Apollon Wealth Management LLC increased its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 419.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,784 shares of the medical research company's stock after buying an additional 7,899 shares during the quarter. Apollon Wealth Management LLC's holdings in Agilent Technologies were worth $1,314,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Van ECK Associates Corp boosted its position in Agilent Technologies by 6.6% in the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company's stock worth $442,011,000 after purchasing an additional 183,716 shares in the last quarter. Vestal Point Capital LP purchased a new position in shares of Agilent Technologies during the 3rd quarter valued at approximately $14,848,000. Empowered Funds LLC lifted its position in shares of Agilent Technologies by 29.8% during the 3rd quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company's stock valued at $4,592,000 after buying an additional 7,111 shares in the last quarter. S.E.E.D. Planning Group LLC lifted its position in shares of Agilent Technologies by 12.7% during the 4th quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company's stock valued at $5,721,000 after buying an additional 4,805 shares in the last quarter. Finally, National Pension Service lifted its position in shares of Agilent Technologies by 10.8% during the 3rd quarter. National Pension Service now owns 702,631 shares of the medical research company's stock valued at $104,327,000 after buying an additional 68,670 shares in the last quarter.
Agilent Technologies Stock Performance
Shares of NYSE:A traded down $1.88 during trading on Friday, reaching $134.57. The company had a trading volume of 1,358,730 shares, compared to its average volume of 1,665,141. The firm has a market capitalization of $38.39 billion, a price-to-earnings ratio of 30.45, a price-to-earnings-growth ratio of 4.00 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The stock's fifty day moving average price is $141.65 and its 200 day moving average price is $139.43. Agilent Technologies, Inc. has a fifty-two week low of $124.16 and a fifty-two week high of $155.35.
Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.41 by $0.05. The business had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The company's revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.38 earnings per share. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 5.56 EPS for the current year.
Agilent Technologies Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were paid a $0.248 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This is an increase from Agilent Technologies's previous quarterly dividend of $0.24. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.74%. Agilent Technologies's payout ratio is 22.40%.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on A. Bank of America decreased their target price on Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating on the stock in a research report on Friday, December 13th. Citigroup lifted their price objective on Agilent Technologies to $165.00 and gave the company a "buy" rating in a research note on Thursday, December 19th. Barclays upgraded Agilent Technologies from an "underweight" rating to an "equal weight" rating and lifted their price objective for the company from $135.00 to $145.00 in a research note on Monday. StockNews.com upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. Finally, Wells Fargo & Company decreased their target price on Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a research note on Monday, December 9th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, Agilent Technologies presently has an average rating of "Moderate Buy" and an average price target of $144.38.
Get Our Latest Stock Report on A
Insider Activity at Agilent Technologies
In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the business's stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Agilent Technologies Profile
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Further Reading
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
